Status:

COMPLETED

Adolescents With Migraine: What's Stress Got To Do With It?

Lead Sponsor:

University of Colorado, Denver

Conditions:

Headache, Migraine

Eligibility:

All Genders

13-17 years

Brief Summary

The overall objective of this proposal is to better define the relationship between perceived stress, hair cortisol, and migraine in adolescents. This will be done by creating 2 arms of the study: tho...

Detailed Description

The overall objective of this proposal is to better define the relationship between perceived stress, hair cortisol, and migraine in adolescents. Although adolescents most frequently report stress as ...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • For Cases:
  • Diagnosis of Migraine as defined by the ICHD-II
  • At least 1 migraine per month
  • For Controls:
  • No diagnosis of Migraine as defined by ICHD-II
  • No diagnosis of Primary Headache Disorders as defined by ICHD-II
  • Exclusion Criteria for Migrainers and Non-migrainers:
  • A secondary headache disorder as defined by ICHD-II
  • A continuous headache (i.e. 24 hours a day every day)
  • An underlying neurological condition such as epilepsy, chiari malformation, or neurocutaneous disorder
  • A chronic medical illness including those illnesses that require chronic steroid use such as asthma, cancer or rheumatologic disorders
  • Subject has bleached hair in past 3 months.
  • Pubertal Tanner stage 1 or 2 (Hair cortisol concentration may depend on developmental stage; 59 Tanner staging will be performed by Dr. Kedia).
  • Subject is pregnant or has a positive pregnancy test.
  • Present psychiatric disease as defined by the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM IV) (e.g. psychosis, bipolar disorder, major depression, generalized anxiety disorder), alcohol or drug dependence, or documented developmental delays or impairments (e.g., autism, cerebral palsy, or mental retardation) that, in the opinion of the site investigator, would interfere with adherence to study requirements or safe participation in the trial
  • Any and all other diagnoses or conditions which in the opinion of the primary investigator would prevent the patient from being a suitable candidate for the study or interfere with the medical care needs of the study subject.

Exclusion

    Key Trial Info

    Start Date :

    September 12 2014

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    October 15 2017

    Estimated Enrollment :

    100 Patients enrolled

    Trial Details

    Trial ID

    NCT02259387

    Start Date

    September 12 2014

    End Date

    October 15 2017

    Last Update

    June 8 2018

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Colorado Children's Hospital

    Aurora, Colorado, United States, 80045